Compare RBB & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | LAB |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.9M | 347.5M |
| IPO Year | 2017 | 2008 |
| Metric | RBB | LAB |
|---|---|---|
| Price | $26.35 | $0.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $22.00 | $1.35 |
| AVG Volume (30 Days) | 267.3K | ★ 5.6M |
| Earning Date | 04-20-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | 24.49 | ★ 61.54 |
| EPS | ★ 0.66 | 0.33 |
| Revenue | $5,167,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $20.50 | N/A |
| Revenue Next Year | $6.90 | $2.63 |
| P/E Ratio | $40.29 | ★ $2.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.74 | $0.70 |
| 52 Week High | $28.20 | $1.72 |
| Indicator | RBB | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 56.25 | 49.64 |
| Support Level | $20.11 | $0.79 |
| Resistance Level | N/A | $1.02 |
| Average True Range (ATR) | 0.82 | 0.07 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 48.68 | 75.28 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.